Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.

Foley, D P; Bonnier, H; Jackson, G; Macaya, C; Shepherd, J; Vrolix, M; Serruys, P W

Foley, D P; Bonnier, H; Jackson, G; Macaya, C; Shepherd, J; Vrolix, M; Serruys, P W.

Affiliation

Foley DP; Thoraxcenter, Erasmus University, Rotterdam, The Netherlands.

Am J Cardiol ; 73(14): 50D-61D, 1994 May 26.

Article in En | MEDLINE | ID: mdl-8198025

Subject(s)

Angioplasty, Balloon, Coronary; Anticholesteremic Agents/therapeutic use; Coronary Disease/prevention & control; Fatty Acids, Monounsaturated/therapeutic use; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles/therapeutic use; Belgium; Combined Modality Therapy; Coronary Angiography; Coronary Disease/diagnostic imaging; Coronary Disease/therapy; Double-Blind Method; Fluvastatin; Humans; Ireland; Lovastatin/therapeutic use; Netherlands; Recurrence; Research Design; Spain; Time Factors; United Kingdom

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids, Monounsaturated / Angioplasty, Balloon, Coronary / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Coronary Disease / Indoles / Anticholesteremic Agents Type of study: Clinical_trials Limits: Humans Country/Region as subject: Europa Language: En Journal: Am J Cardiol Year: 1994 Document type: Article Affiliation country: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links